UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S375 - S376
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S228 - S229
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S33 - S34
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 05/2019, Volume 143, Issue 5, pp. 1934 - 1937.e4
Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Corticoids | Health care | Pediatrics | Parents | Colleges & universities | Immunoglobulin E | Wheezing | Blood | Education | Facsimile communication | Race | Children | Rainbows | Emergency medical services | Public health | Medical personnel | Spears | Phenotypes | Corticosteroids | Enrollments | Hypersensitivity | Feasibility studies | Health care facilities | Minority & ethnic groups | Children & youth | Asthma | Medicine | Babies | Preschool children | Informed consent | Rosemary | Skin | Skin tests | Index Medicus | Abridged Index Medicus | Preschool Wheezing | Lower respiratory tract infections | Preschool-aged Children | oral corticosteroids | efficacy | multi-center clinical trial
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 2, pp. S81 - S82
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 2, pp. S304 - S304
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 2018, Volume 54, Issue 8, pp. 1245 - 1253
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Treatment outcome | Usage | Analysis | Stem cells | Dosage and administration | Busulfan | Graft-versus-host reaction | Intravenous administration | Transplants & implants | Toxicity | Myeloid leukemia | Leukemia | Stem cell transplantation | Survival | Myelodysplastic syndrome | Fludarabine | Chimerism | Conditioning | Acute myeloid leukemia | Index Medicus
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 04/2017, Volume 52, Issue 4, pp. 580 - 587
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Recurrence | Humans | Middle Aged | Male | Drug Monitoring - methods | Hematopoietic Stem Cell Transplantation - mortality | Busulfan - administration & dosage | Transplantation Conditioning - mortality | Transplantation, Homologous - mortality | Myelodysplastic Syndromes - therapy | Adult | Female | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Leukemia, Myeloid, Acute - therapy | Busulfan - pharmacokinetics | Treatment Outcome | Vidarabine - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - toxicity | Busulfan - toxicity | Leukemia, Myeloid, Acute - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Myelodysplastic Syndromes - mortality | Survival Analysis | Vidarabine - administration & dosage | Hematopoietic Stem Cell Transplantation - methods | Transplantation, Homologous - methods | Usage | Dosage and administration | Fludarabine | Busulfan | Stem cells | Index Medicus
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 11/2014, Volume 74, Issue 5, pp. 927 - 938
Medicine & Public Health | Oncology | Cancer Research | Bone marrow transplant | Busulfan | Pharmacology/Toxicology | Pharmacokinetics | Elderly | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Busulfan - blood | Acute Disease | Age Factors | Busulfan - pharmacokinetics | Area Under Curve | Humans | Middle Aged | Male | Metabolic Clearance Rate | Myeloablative Agonists - pharmacokinetics | Myeloablative Agonists - blood | Leukemia, Myeloid - metabolism | Female | Aged | Hematopoietic Stem Cell Transplantation - methods | Leukemia, Myeloid - therapy | Antimitotic agents | Medical research | Analysis | Leukemia | Mortality | Medicine, Experimental | Transplantation | Hematopoietic stem cells | Index Medicus | busulfan | pharmacokinetics | bone marrow transplant | elderly
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 10, pp. 1792 - 1800
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2011, Volume 17, Issue 12, pp. 1874 - 1877
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | FLT3 | Acute myeloid leukemia | Sorafenib | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Niacinamide - analogs & derivatives | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | fms-Like Tyrosine Kinase 3 - biosynthesis | Recurrence | Prognosis | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Benzenesulfonates - administration & dosage | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Leukemia, Myeloid, Acute - enzymology | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Leukemia, Myeloid, Acute - surgery | Retrospective Studies | Pyridines - therapeutic use | Pyridines - administration & dosage | Combined Modality Therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Aged | Hematopoietic Stem Cell Transplantation - methods | Leukemia, Myeloid, Acute - genetics | Transplantation, Homologous - methods | Tyrosine | Relapse | Care and treatment | Genes | Antineoplastic agents | Hematopoietic stem cells | Diseases | Antimitotic agents | Chemotherapy | Stem cells | Bone marrow | Phosphotransferases | Cancer | Index Medicus
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1948 - 1954
Hematology, Oncology and Palliative Medicine | Relapse | Chimerism | Acute myeloid leukemia | Myelodysplastic syndrome | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Myeloablative Agonists - therapeutic use | Recurrence | Prognosis | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Transplantation, Homologous | Myelodysplastic Syndromes - therapy | Graft vs Host Disease - mortality | Adult | Female | Retrospective Studies | T-Lymphocytes - pathology | Leukemia, Myeloid, Acute - therapy | Busulfan - therapeutic use | Leukemia, Myeloid, Acute - pathology | Hematopoietic Stem Cell Transplantation | Graft Survival | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Transplantation Chimera | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Myelodysplastic Syndromes - mortality | Survival Analysis | Graft vs Host Disease - prevention & control | T-Lymphocytes - immunology | Transplantation Conditioning | Myelodysplastic Syndromes - pathology | Myelodysplastic Syndromes - immunology | Analysis | Stem cells | Development and progression | T cells | Hematopoietic stem cells | Diseases | Index Medicus
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 6, pp. 898 - 903
Hematology, Oncology and Palliative Medicine | AML | Stem cell transplantation | Transplant outcomes | T cell depletion | GVHD | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Graft vs Host Disease - therapy | Recurrence | Thiotepa - administration & dosage | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Lymphocyte Depletion | Antilymphocyte Serum - administration & dosage | Busulfan - administration & dosage | Graft vs Host Disease - immunology | Transplantation, Homologous | Graft vs Host Disease - mortality | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | T-Lymphocytes - pathology | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Vidarabine - analogs & derivatives | Remission Induction | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Melphalan - administration & dosage | Survival Analysis | T-Lymphocytes - immunology | Aged | Vidarabine - administration & dosage | Medical colleges | Cyclophosphamide | Histocompatibility antigens | Tacrolimus | HLA histocompatibility antigens | Homografts | Stem cells | Lectins | Methotrexate | T cells | Index Medicus
Journal Article